India to France: Trimethoprim Export Trade Route

The India to France Trimethoprim corridor is one of India's established pharmaceutical export routes, with 29 shipments documented worth a combined $810.4K USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 43% of all export value, reflecting the consolidated nature of India's trimethoprim manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $27.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 26.6%, placing it at rank #2 among India's top trimethoprim export destinations globally.

On the import side, key buyers of Indian trimethoprim in France include LABORATOIRE BAILLY CREAT, E.P.DIS, EURIMAX PHARMA and 2 others. LABORATOIRE BAILLY CREAT is the single largest importer with 16 shipments valued at $346.1K USD.

India's trimethoprim exports to France are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDREICH LIMITED, GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED, DEVATS INDIA PRIVATE LIMITED — together account for 87% of total trade value on this route. The average shipment value of $27.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as artecom- dihydroartemisinin 32mg + piperaquine 320 mg + trimethoprim 90 mg tablet and artecom - dihydroartemisinin 32mg + piperaquine 320 mg + trimethoprim 90 mg tablet, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATOIRE BAILLY CREAT is the largest importer with 16 shipments worth $346.1K USD — representing 43% of all trimethoprim imports from India on this route.